Why the study?
Do home or ambulatory blood pressure monitoring reliably diagnose hypertension compared to repeated clinic blood pressure measurements in untreated subjects with elevated initial clinic blood pressure?
Do home or ambulatory blood pressure monitoring reliably diagnose hypertension compared to repeated clinic blood pressure measurements in untreated subjects with elevated initial clinic blood pressure?
Indiscriminate use of home or ambulatory blood pressure monitoring for all subjects with high blood pressure may cause diagnostic confusion, though home monitoring is useful as a screening test for white coat hypertension.
Answers are grounded in this paper and cite their sources.
Modest agreement across BP methods risks inconsistent diagnoses; leaves open optimal confirmatory strategy in untreated patients.
The objective of the study was to investigate whether measurement of blood pressure at home (HBP) or by ambulatory monitoring (ABP) are reliable alternatives to the traditional strategy for hypertension diagnosis based on blood pressure measurement on repeated clinic visits (CBP). A total of 133 untreated subjects with diastolic CBP 90–115 mmHg on the initial visit were evaluated with HBP (6 workdays), ABP monitoring (2 occasions) and CBP (5 visits within 3 months). The diagnostic value of the HBP and the ABP method was compared to the conventional CBP strategy. Hypertension was diagnosed in 57%, 54% and 45% of subjects using the CBP, ABP and HBP methods respectively (p=NS). Agreement in the diagnosis of hypertension between all three methods was found in 59% of cases. Disagreement between CBP/ABP was found in 27%, CBP/HBP in 28% and ABP/HBP in 28% of cases. The sensitivity, specificity, positive and negative predictive value of ABP to diagnose hypertension correctly were 73%, 73%, 79% and 66% respectively and of HBP 64%, 84%, 85% and 62%. The above parameters for HBP compared to ABP in the detection of white coat hypertension were 67%, 87%, 50% and 93% respectively. These data suggest that indiscriminate use of HBP or ABP monitoring in the evaluation of all subjects with high blood pressure will probably result in confusion and therefore should be discouraged. However, in the detection of white coat hypertension, HBP appears to be useful as a screening test, which, if positive, requires confirmation with ABP monitoring.
No takes yet. Share an insight, caveat, or question.
George S. Stergiou (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: